![](/img/cover-not-exists.png)
A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52)
von Minckwitz, Gunter, Conrad, Bettina, Reimer, Toralf, Decker, Thomas, Eidtmann, Holger, Eiermann, Wolfgang, Hackmann, John, Möbus, Volker, Marmé, Frederik, Potenberg, Jochem, Stickeler, Elmar, SimonVolume:
121
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.29506
Date:
October, 2015
File:
PDF, 376 KB
english, 2015